Related Experiment Video

Updated: Dec 21, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K

Small dense low-density lipoprotein-lowering agents

Shahin Alizadeh-Fanalou1,2, Ali Nazarizadeh2, Fatemeh Alian3

  • 1Student Research Committee, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Biological Chemistry
|May 20, 2020
PubMed

Insights

Small dense low-density lipoprotein (sdLDL) is a key marker for cardiovascular disease and atherosclerosis. Lifestyle, diet, and medications can effectively lower sdLDL levels, improving cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Lipid Metabolism

Background:

  • Metabolic and cardiovascular diseases (CVD), including atherosclerosis, are leading global causes of mortality.
  • Plasma low-density lipoprotein (LDL) levels are critical risk factors, with small dense LDL (sdLDL) subclasses being particularly implicated in atherosclerosis.
  • sdLDL levels offer a promising alternative for monitoring CVD and early atherosclerosis diagnosis.

Purpose of the Study:

  • To elucidate the production pathways of sdLDL particles.
  • To review the impact of pharmaceutical, dietary, and lifestyle interventions on plasma sdLDL levels.
  • To discuss the mechanisms of action for agents that modulate sdLDL.

Main Methods:

  • Literature review of studies on sdLDL production and modulation.
  • Analysis of mechanisms of action for cholesterol-lowering drugs and dietary components.
  • Examination of lifestyle factors influencing lipid profiles and sdLDL levels.

Main Results:

  • Cholesterol and LDL-lowering agents are effective in reducing sdLDL levels.
  • Improvements in the overall lipid profile, particularly triglyceride reduction, contribute to decreased sdLDL.
  • Lifestyle modifications and appropriate dietary regimens play a significant role in lowering sdLDL.

Conclusions:

  • sdLDL is a significant biomarker for cardiovascular risk and atherosclerosis.
  • A multifaceted approach, including pharmacological, dietary, and lifestyle interventions, is crucial for managing sdLDL levels.
  • Simultaneous consideration of lipid profile, triglyceride levels, diet, and lifestyle is essential for effective sdLDL reduction strategies.

Keywords:
atherosclerosiscardiovascular diseases (CVD)cholesterolsmall dense low-density lipoproteintriglyceride

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.9K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.2K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
497
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
528
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.3K